within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03A_HormonalContraceptivesForSystemicUse.G03AA05_NorethisteroneAndEthinylestradio;

model NorethisteroneAndEthinylestradio
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.4,
    Cl = 6.944444444444445e-07,
    adminDuration = 600,
    adminMass = 1 / 1000000,
    adminCount = 1,
    Vd = 0.06,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.02,
    Tlag = 600);

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>NorethisteroneAndEthinylestradiol</td></tr><tr><td>ATC code:</td><td>G03AA05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Combination oral contraceptive containing norethisterone (a progestin) and ethinylestradiol (an estrogen), used for birth control. Widely approved and in use as a contraceptive agent worldwide.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult females, using typical dose regimens and literature data for individual components. No direct clinical population PK publication reporting a model for the combined preparation (G03AA05) as a unit.</p><h4>References</h4><ol><li><p>Kiriwat, O, &amp; Fotherby, K (1983). Pharmacokinetics of oral contraceptive steroids after morning or evening administration. <i>Contraception</i> 27(2) 153–160. DOI:<a href=\"https://doi.org/10.1016/0010-7824(83)90086-0\">10.1016/0010-7824(83)90086-0</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6851554/\">https://pubmed.ncbi.nlm.nih.gov/6851554</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G03AA05 folded in (Drugs.ATC removed)</li><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end NorethisteroneAndEthinylestradio;
